Actively Recruiting

Age: 5Years +
All Genders
Healthy Volunteers
ID06839469

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Led by Columbia University · Updated on 2026-04-09

106

Participants Needed

3

Research Sites

13 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

S

Stevens Institute of Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research focuses on two rare childhood-onset progressive neuromuscular disorders: spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). The study aims to identify walking-related digital biomarkers that reflect disease severity and to monitor changes over time in natural settings. These disorders cause progressive muscle weakness and functional decline, and the study seeks to better understand real-world walking function in affected children and adults. Participants will wear specially developed instrumented insoles that collect walking data both in the lab and during daily life. The study groups include ambulatory children and adults aged 5 years and older with genetically confirmed SMA or DMD, as well as a healthy control group matched by age and gender. The sensors' data will be analyzed using machine-learning models to derive accurate gait parameters that may serve as functional biomarkers. Throughout the study, participants will undergo several physical assessments such as the Six Minute Walk Test, 10 Meter Walk/Run, Time Up and Go Test, muscle strength testing, and joint range of motion measurements on a single day. Additionally, free-living activity will be monitored for one month using the instrumented insoles and an Actigraph accelerometer. Questionnaires on physical activity will also be completed. These measures will help researchers track disease progression and real-world mobility over an extended period. The study is expected to continue until April 2028.

CONDITIONS

Brief Title

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Who Can Participate

Age: 5Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Genetic confirmation of Duchenne muscular dystrophy, spinal muscular atrophy, or healthy control
  • Able to walk independently at least 25 meters
  • For DMD: ongoing corticosteroid therapy or started corticosteroids within the past 3 months
  • For SMA: stable dose of FDA-approved SMN up-regulator therapy for at least 6 months, or in an open-label extension study, or gene replacement therapy at enrollment
Not Eligible

You will not qualify if you...

  • Use of foot orthoses, assistive devices for walking in the community, or mobility devices for community navigation
  • Use of investigational medications for neuromuscular disorders within 30 days
  • Injury or surgery impacting gait within the previous 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants complete walking and muscle function tests while wearing instrumented insoles to assess gait parameters.

1 visit (in-person)

Long-term Monitoring

Duration - 1 month

Participants wear instrumented insoles and accelerometers in real-life environments to collect walking and physical activity data.

Continuous monitoring over 1 month with periodic data collection

Trial Site Locations

Total: 3 locations

1

Stanford University

Palo Alto, California, United States, 94304

Actively Recruiting

2

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

3

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

J

Jacqueline Montes, PT, EdD

C

Cara Kanner, DPT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study...

Duchenne Muscular Dystrophy (DMD)

Actively Recruiting

14 locations

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study...

Duchenne Muscular Dystrophy (DMD)

Actively Recruiting

15 locations

A Phase 2, Double-Blind Study to Evaluate the Pharmacokineti...

Spinal Muscular Atrophy

Actively Recruiting

25 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here